SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021936
Filing Date
2022-11-03
Accepted
2022-11-03 16:33:58
Documents
93
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbio-20220930.htm   iXBRL 10-Q 5883761
2 EX-31.1 bbio-ex31_1.htm EX-31.1 34696
3 EX-31.2 bbio-ex31_2.htm EX-31.2 34816
4 EX-32.1 bbio-ex32_1.htm EX-32.1 16281
5 EX-32.2 bbio-ex32_2.htm EX-32.2 16608
  Complete submission text file 0000950170-22-021936.txt   20189885

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbio-20220930_pre.xml EX-101.PRE 613507
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbio-20220930.xsd EX-101.SCH 113832
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbio-20220930_lab.xml EX-101.LAB 806533
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbio-20220930_cal.xml EX-101.CAL 83112
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbio-20220930_def.xml EX-101.DEF 437914
87 EXTRACTED XBRL INSTANCE DOCUMENT bbio-20220930_htm.xml XML 4462062
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 221358605
SIC: 2834 Pharmaceutical Preparations